Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
International comparison of treatment strategy and survival in metastatic gastric cancer
Leiden Univ, Med Ctr, Dept Surg, K6-R,POB 9600, NL-2300 RC Leiden, Netherlands.
Leiden Univ, Med Ctr, Dept Surg, K6-R,POB 9600, NL-2300 RC Leiden, Netherlands;Leiden Univ, Med Ctr, Dept Med Oncol, Leiden, Netherlands.
Leiden Univ, Med Ctr, Dept Surg, K6-R,POB 9600, NL-2300 RC Leiden, Netherlands.
Leiden Univ, Med Ctr, Dept Surg, K6-R,POB 9600, NL-2300 RC Leiden, Netherlands.
Show others and affiliations
2019 (English)In: BJS OPEN, ISSN 2474-9842, Vol. 3, no 1, p. 56-61Article in journal (Refereed) Published
Abstract [en]

BackgroundIn the randomized Asian REGATTA trial, no survival benefit was shown for additional gastrectomy over chemotherapy alone in patients with advanced gastric cancer with a single incurable factor, thereby discouraging surgery for these patients. The purpose of this study was to evaluate treatment strategies for patients with metastatic gastric cancer in daily practice in five European countries, along with relative survival in each country. MethodsNationwide population-based data from Belgium, Denmark, the Netherlands, Norway and Sweden were combined. Patients with primary metastatic gastric cancer diagnosed between 2006 and 2014 were included. The proportion of gastric resections performed and the administration of chemotherapy (irrespective of surgery) within each country were determined. Relative survival according to country was calculated. ResultsOverall, 15 057 patients with gastric cancer were included. The proportion of gastric resections varied from 81 per cent in the Netherlands and Denmark to 183 per cent in Belgium. Administration of chemotherapy was 392 per cent in the Netherlands, compared with 632 per cent in Belgium. The 6-month relative survival rate was between 390 (95 per cent c.i. 378 to 402) per cent in the Netherlands and 541 (521 to 569) per cent in Belgium. ConclusionThere is variation in the use of gastrectomy and chemotherapy in patients with metastatic gastric cancer, and subsequent differences in survival.

Place, publisher, year, edition, pages
JOHN WILEY & SONS LTD , 2019. Vol. 3, no 1, p. 56-61
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:uu:diva-377218DOI: 10.1002/bjs5.103ISI: 000457222900007PubMedID: 30734016OAI: oai:DiVA.org:uu-377218DiVA, id: diva2:1289219
Available from: 2019-02-15 Created: 2019-02-15 Last updated: 2019-02-15Bibliographically approved

Open Access in DiVA

fulltext(186 kB)63 downloads
File information
File name FULLTEXT01.pdfFile size 186 kBChecksum SHA-512
b07e6b1c7a2522cb87bfa97a1fda62b229e41a75db953a5f5191cfa691f11a21ff1bdb22d95640dd12f0797b3d889ce6c1cd1b279454da7826398de7a3b80aa8
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Hedberg, Jakob
By organisation
Upper Abdominal Surgery
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
Total: 63 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 126 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf